Institution Notes

Mayo Clinic, Yale join NCCN network

The National Comprehensive Cancer Network announced Mayo Clinic Cancer Center and Yale Cancer Center/Smilow Cancer Hospital have been named the newest NCCN member institutions.

“These institutions exemplify the best in cancer care and cancer research. Each has unique attributes that will strengthen our network and improve care for patients with cancer,” Samuel M. Silver, MD, PhD, chair of the NCCN board of directors and a HemOnc Today Editorial Board member, said in a press release.

Samuel M. Silver, MD, PhD, MACP 

Samuel M. Silver

Mayo Clinic Cancer Center is an NCI-designated comprehensive cancer center with campuses in Phoenix/Scottsdale, Ariz., Jacksonville, Fla., and Rochester, Minn.,

“NCCN and the Mayo Clinic share a mission to better the lives of cancer patients,” said Robert Diasio, MD, director of Mayo Clinic Cancer Center. “We are excited to work with other NCCN member institutions to save lives and improve quality of life for cancer patients across the nation.”

Yale Cancer Center/Smilow Cancer Hospital also is an NCI-designated comprehensive cancer center, which incorporates the resources of Smilow Cancer Hospital at Yale-New Haven and Yale School of Medicine.

“We are honored to be elected to NCCN institutional membership,” said Thomas J. Lynch Jr., MD, director of Yale Cancer Center and physician in chief at Smilow Cancer Hospital at Yale-New Haven. “The collaboration of over 450 scientists and physicians focused on cancer research and care at Yale provides a strong foundation for breakthroughs in cancer prevention, diagnosis and treatment.”

The National Comprehensive Cancer Network announced Mayo Clinic Cancer Center and Yale Cancer Center/Smilow Cancer Hospital have been named the newest NCCN member institutions.

“These institutions exemplify the best in cancer care and cancer research. Each has unique attributes that will strengthen our network and improve care for patients with cancer,” Samuel M. Silver, MD, PhD, chair of the NCCN board of directors and a HemOnc Today Editorial Board member, said in a press release.

Samuel M. Silver, MD, PhD, MACP 

Samuel M. Silver

Mayo Clinic Cancer Center is an NCI-designated comprehensive cancer center with campuses in Phoenix/Scottsdale, Ariz., Jacksonville, Fla., and Rochester, Minn.,

“NCCN and the Mayo Clinic share a mission to better the lives of cancer patients,” said Robert Diasio, MD, director of Mayo Clinic Cancer Center. “We are excited to work with other NCCN member institutions to save lives and improve quality of life for cancer patients across the nation.”

Yale Cancer Center/Smilow Cancer Hospital also is an NCI-designated comprehensive cancer center, which incorporates the resources of Smilow Cancer Hospital at Yale-New Haven and Yale School of Medicine.

“We are honored to be elected to NCCN institutional membership,” said Thomas J. Lynch Jr., MD, director of Yale Cancer Center and physician in chief at Smilow Cancer Hospital at Yale-New Haven. “The collaboration of over 450 scientists and physicians focused on cancer research and care at Yale provides a strong foundation for breakthroughs in cancer prevention, diagnosis and treatment.”